Blog

featured image of Revolutionary Microfluidics: The Future of Personalized Medicine

Revolutionary Microfluidics: The Future of Personalized Medicine

BIOT

🧪 Microfluidics + 🔬 = 💰 & 💉. Discover how personalized medicine can benefit from this powerful combination.

featured image of Unlocking Profitable Therapies: The Power of Techno-Economic Analysis

Unlocking Profitable Therapies: The Power of Techno-Economic Analysis

BIOT

🔬📊 Bioprocessing needs sustainable & profitable therapies. Techno-economic analysis helps evaluate production processes, like the bioprocess TEA calculator. 🌱💰 However, challenges will persist as the industry evolves.

featured image of Ligand Pharma Snaps Up Apeiron Biologics for $100M

Ligand Pharma Snaps Up Apeiron Biologics for $100M

BIOT

📢 Ligand Pharma acquires Apeiron Biologics for $100M, invests $4M in invIOs Holding AG, and offers future event-based considerations. 🏢💰🏥🤝📅

featured image of Exciting Partnership Expands EuroscreenFast's Reach in Korea!

Exciting Partnership Expands EuroscreenFast’s Reach in Korea!

BIOT

📢 EuroscreenFast and GW Vitek join forces in Korea, expanding market reach and offering cutting-edge GPCR screening technologies. 🤝🌍💼

featured image of Breaking News: EuroscreenFast and GW Vitek Join Forces to Revolutionize Korean Market

Breaking News: EuroscreenFast and GW Vitek Join Forces to Revolutionize Korean Market

BIOT

📢 Belgian screening specialist EuroscreenFast and Asian distributor GW Vitek join forces for strategic collaboration in Korea! 🌍🤝🚀

featured image of EMA-Gate: PharmaMar Triumphs Against Conflicts of Interest

EMA-Gate: PharmaMar Triumphs Against Conflicts of Interest

BIOT

🔍 PharmaMar wins suit against EMA experts for conflicts of interest in non-authorization of Aplidin. 💊👨‍⚖️💰 EMAGate

featured image of Evotec and Sandoz Join Forces for Biosimilar Breakthrough

Evotec and Sandoz Join Forces for Biosimilar Breakthrough

BIOT

📢 Just – Evotec Biologics expands partnership with Sandoz, providing biosimilars and enhancing patient access. 🧪🤝 BiosimilarDevelopment

featured image of Revolutionary Microbe Boosters: Unleashing Resilient Manufacturing Superheroes

Revolutionary Microbe Boosters: Unleashing Resilient Manufacturing Superheroes

BIOT

🌌💪🔬 MIT researchers discover how to make microbes resilient by mixing them with FDA-approved additives. Implications for space missions. 🚀💡

featured image of Unlocking the Secrets of AAVs: Game-Changing Gene Therapy

Unlocking the Secrets of AAVs: Game-Changing Gene Therapy

BIOT

🧬 Analyzing AAV charge heterogeneity just got easier! Discover how high-resolution icIEF fractionation with LC-MS analysis revolutionizes gene therapy development. 🌟

featured image of Cancer ADC Specialist Myricx Bio Secures £90m in Funding Expanding Pipeline and Board

Cancer ADC Specialist Myricx Bio Secures £90m in Funding Expanding Pipeline and Board

BIOT

📢 Novo Holdings AS and Abingworth co-lead £90m financing in Myricx Bio Ltd, with plans to expand their ADC platform. 💰